These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22605647)

  • 21. Routine culture and differentiation of human embryonic stem cells.
    McWhir J; Wojtacha D; Thomson A
    Methods Mol Biol; 2006; 331():77-90. PubMed ID: 16881510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers.
    Wang G; Zhang H; Zhao Y; Li J; Cai J; Wang P; Meng S; Feng J; Miao C; Ding M; Li D; Deng H
    Biochem Biophys Res Commun; 2005 May; 330(3):934-42. PubMed ID: 15809086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional assays for human embryonic stem cell pluripotency.
    O'Connor MD; Kardel MD; Eaves CJ
    Methods Mol Biol; 2011; 690():67-80. PubMed ID: 21042985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene silencing of human RAMP2 mediated by short-interfering RNA.
    Albertin G; Ruggero M; Guidolin D; Nussdorfer GG
    Int J Mol Med; 2006 Oct; 18(4):531-5. PubMed ID: 16964401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic manipulation of human embryonic stem cells.
    Epsztejn-Litman S; Eiges R
    Methods Mol Biol; 2010; 584():387-411. PubMed ID: 19907989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Matrigel and gelatin substrata for feeder-free culture of undifferentiated mouse embryonic stem cells for toxicity testing.
    Greenlee AR; Kronenwetter-Koepel TA; Kaiser SJ; Liu K
    Toxicol In Vitro; 2005 Apr; 19(3):389-97. PubMed ID: 15713546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods for culturing mouse and human embryonic stem cells.
    Lin S; Talbot P
    Methods Mol Biol; 2011; 690():31-56. PubMed ID: 21042983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial commitment from human pluripotent stem cells: Rapid production of human heart grafts.
    Garreta E; de Oñate L; Fernández-Santos ME; Oria R; Tarantino C; Climent AM; Marco A; Samitier M; Martínez E; Valls-Margarit M; Matesanz R; Taylor DA; Fernández-Avilés F; Izpisua Belmonte JC; Montserrat N
    Biomaterials; 2016 Aug; 98():64-78. PubMed ID: 27179434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic manipulation of human induced pluripotent stem cells.
    Wang A; Liew CG
    Curr Protoc Stem Cell Biol; 2012 Nov; Chapter 5():Unit 5B.2. PubMed ID: 23154936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of hepatocytes from pluripotent stem cells.
    Mallanna SK; Duncan SA
    Curr Protoc Stem Cell Biol; 2013 Sep; 26():1G.4.1-1G.4.13. PubMed ID: 24510789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptation of human pluripotent stem cells to feeder-free conditions in chemically defined medium with enzymatic single-cell passaging.
    Stover AE; Schwartz PH
    Methods Mol Biol; 2011; 767():137-46. PubMed ID: 21822872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New methods for reverse transfection with siRNA from a solid surface.
    Fujita S; Takano K; Ota E; Sano T; Yoshikawa T; Miyake M; Miyake J
    Methods Mol Biol; 2010; 623():197-209. PubMed ID: 20217553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xeno-free culture of human pluripotent stem cells.
    Bergström R; Ström S; Holm F; Feki A; Hovatta O
    Methods Mol Biol; 2011; 767():125-36. PubMed ID: 21822871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective gene suppression using small interfering RNA in hard-to-transfect human T cells.
    Yin J; Ma Z; Selliah N; Shivers DK; Cron RQ; Finkel TH
    J Immunol Methods; 2006 May; 312(1-2):1-11. PubMed ID: 16603179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lentivirus-mediated modification of pluripotent stem cells.
    Bajpai R
    Methods Mol Biol; 2011; 767():315-31. PubMed ID: 21822885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.
    Abraham S; Sheridan SD; Miller B; Rao RR
    Biotechnol Prog; 2010; 26(4):1126-34. PubMed ID: 20730767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microarray Approach to Identify the Signaling Network Responsible for Self-Renewal of Human Embryonic Stem Cells.
    Sato N; Brivanlou A
    Methods Mol Biol; 2016; 1307():71-88. PubMed ID: 25990842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of human embryonic stem cells carrying lineage specific reporters.
    Noisa P; Urrutikoetxea-Uriguen A; Cui W
    Methods Mol Biol; 2011; 690():95-106. PubMed ID: 21042987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts.
    Mali P; Ye Z; Hommond HH; Yu X; Lin J; Chen G; Zou J; Cheng L
    Stem Cells; 2008 Aug; 26(8):1998-2005. PubMed ID: 18511599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency.
    Gerrard L; Zhao D; Clark AJ; Cui W
    Stem Cells; 2005; 23(1):124-33. PubMed ID: 15625129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.